Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Teldarpaperon Sep 19, 2018 6:08pm
39 Views
Post# 28651098

RE:RE:RE:RE:RE:Shorts

RE:RE:RE:RE:RE:Shorts
Good advice - I also heard of value investing by A Dodd and B Graham. Theres also Peter Lynch etc. 

What are view points on a CEO of a MJ company that negatively comments on market opportuntiies to enhance his business? 

What are your view points on the constant re-addresses of press releases since IR with 15 years of IB experience still can't spell or double check his work? 

What about that interim chairman - has he addressed the OSC investigation yet? Wheres the special committee on this? 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities